Showing results (31-40 of 255) with videos related to
Sort By:
Pageof 26
Bulletin Du Cancer|December 26, 2009
[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value]D Planchard, Y Loriot, B BesseRevue De Pneumologie Clinique|July 1, 2008
[Management of targeted molecular therapies toxicities in thoracic cancerology]S Rajpar, A Osio, B BesseCancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Treatment of nasopharyngeal cancer: literature review]G Noël, B Dessard-Diana, S Vignot, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Controversies and challenges regarding the impact of radiation therapy on survivalC Chargari, J-C Soria, E DeutschBulletin Du Cancer|October 15, 1998
[Epidermoid carcinoma of the penis]J C Soria, C Theodore, A GerbauletAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Tumour stem cell-targeted treatment: elimination or differentiationC Massard, E Deutsch, J-C SoriaAnnals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerE Deutsch, C Le Péchoux, L Faivre, et al.Bulletin Du Cancer|May 21, 2010
[Histone deacetylase inhibitors: highlight on epigenetic regulation]N Pécuchet, T Cluzeau, C Thibault, et al.Cancer Treatment Reviews|January 23, 2017
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment eraJ Remon, E Le Rhun, B BesseAnnals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2011
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)T C Gauler, B Besse, A Mauguen, et al.Pageof 26